RxBenefit Clarity™ Helps Improve Medication Adherence by nearly 20 Percent
COLUMBUS, OH, Feb. 7, 2019 - RxBenefit Clarity™, a medication decision support platform developed by CoverMyMeds and RelayHealth Pharmacy Solutions, has been trusted by providers to deliver accurate prescription pricing information more than 125 million times in less than a year. More than a dozen EHRs and Epic health systems have collaborated with CoverMyMeds to offer RxBenefit Clarity to providers across the U.S., including Allscripts, Amazing Charts, athenahealth, Cerner, eMDs and NewCrop.
Now, more than 470,000 U.S. providers have access to RxBenefit Clarity, a one-stop shop within the prescribing workflow that works with all health care stakeholders to display medication alternatives and the lowest patient pay amount for prescriptions through comprehensive analysis.
Since launch, RxBenefit Clarity has remained the most accurate and reliable real-time benefit check solution available today. In a recent case study, one of the largest EHRs in the market reported a 97 percent accuracy rate for patient pay amount and a nearly 20 percent increase in medication adherence.CoverMyMeds Case Study: Improving Prescription Decision Support with RxBenefit Clarity™, 2019 Copies of the full RxBenefit Clarity case study can be downloaded here and will be available at HIMSS19, booth 3278.
At HIMSS19 on Wednesday, February 13 at 3:00 p.m. in booth 3278, CoverMyMeds will host a panel discussion with leaders from athenahealth, eMDs and the University of Virginia Health System to uncover how health stakeholders across the industry are collaborating to develop cutting-edge solutions, which improve patient pay visibility, adherence and time-to-therapy for medications. The panel will analyze current prescription price transparency trends and include insights from the RxBenefit Clarity case study, as well as the 2018 Real-Time Benefit Check National Adoption Scorecard.
“Before RxBenefit Clarity, I didn’t have immediate visibility into the cost of the drug I was prescribing. I couldn’t share cost information, adjust my choices or present informed options that might help my patients adhere to their therapies,” said Eric Weidmann, MD, Chief Medical Officer of eMDs. “Having the ability to share the price of the prescription has helped give my patients confidence that they can afford their prescribed therapies, and helps give me insight that I wish I could have had throughout my career. I’m looking forward to participating in Wednesday’s panel discussion to share my experiences with the tool, and I encourage everyone who has an interest in helping patients get on—and stay on—their therapies to join us for this important conversation.”
Those attending HIMSS19 February 11 – 15, 2019 can visit CoverMyMeds at booth 3278 to learn more about CoverMyMeds’ solutions that help patients get the medications they need to live healthy lives.